Pharmaceutical companies are leveraging artificial intelligence and improved data systems to accelerate drug development. Executives from Sanofi and Everpure outlined how better data infrastructure enables faster discovery and development cycles.
The pharmaceutical industry is increasingly adopting AI-driven approaches to streamline drug development processes. According to discussions between industry leaders, including Pradeep Bandaru, Head of Platforms & AI Workflows at Sanofi, and Shawn Rosemarin, Global VP of Research & Development at Everpure, data quality and accessibility are critical factors in this transformation.
AI systems can process vast amounts of research data to identify promising drug candidates and predict outcomes more efficiently than traditional methods. This capability reduces development timelines and costs while improving success rates in clinical trials.
The shift reflects broader industry recognition that computational approaches complement traditional pharmaceutical research. Companies investing in AI platforms and data infrastructure are positioning themselves to compete more effectively in drug discovery. As data becomes more sophisticated and AI models improve, pharmaceutical firms expect accelerated innovation cycles and better outcomes for patients awaiting new treatments.
OpenAI has improved ChatGPT's Voice Mode with more natural conversation capabilities. The update reduces awkward pauses and makes verbal interactions feel closer to talking with another person.
AI detection tools designed to catch machine-generated text are triggering widespread skepticism about content authenticity, mirroring decades of anti-plagiarism software use in education and publishing.
Britain's employment courts face a crisis as AI-generated filings surge 39 percent year-over-year through March 2026. The backlog has swollen to 64,000 unresolved cases, with many submissions containing fabricated legal citations and excessive length.
Meetily provides an open-source alternative for transcribing and summarizing virtual meetings at no cost. The tool eliminates the need for paid subscription services.